Opinions
Chris Damas
MedReleaf Corp.
LEAF-T
COMMENT
Jul 06, 2017
$7.970
Stock price when the opinion was issued
0
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
Advertising
They are the forth of the top names. The company seems to be a game changer in terms of production per square foot with an indoor grow. He does not know how many patients they have, which some companies do disclose.